fda glp-1 news november 2025 dominates for trial activity FDA Accepts NDA Submission for

As always, its best to talk to your doctor about whether taking them together is right for you and how to adjust your diet and medication schedule to minimize side effects

Interestingly, the activated fibroblast phenotype, which is more proliferative and pro-inflammatory, is particularly pronounced in OA patients with obesity [88,89,90], even in non-load bearing joints i.e

Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M, et al

antiplatelet therapy

As a chemist who has spent much of my career at the interface of analytical science and manufacturing, I see this next chapter of GLP-1s primarily as a manufacturing story